Government officials are concerned about how Google will leverage the its control of Fitbit data to become more powerful. The U.S. Department of Justice’s antitrust division is investigating the deal, a person familiar with the matter told Bloomberg.
Antitrust lawmakers are debating how privacy lapses could raise competition concerns, reports Bloomberg. In the European Union, officials expect the merger to undergo an extensive review, as there has been heightened pressure to crack down on technology giants. Authorities in Australia are also monitoring the deal.
One way antitrust enforcers could argue against the merger is by claiming that Fitbit’s user data will complement Google’s data and enable Google to maintain its monopoly, Bloomberg reports. Additionally, antitrust lawmakers could suggest that Google would fail to support Fitbit’s privacy protections over time.
Google declined to comment to Bloomberg, and Fitbit did not immediately respond to a request for comment.
More articles on health IT:
HBR: The 7 jobs of the chief data officer
Brigham and Women’s study: Innovation depends on more than hospital profits — patients have to be on board, too
CEOs feel more confident about cybersecurity efforts
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
